Oppenheimer lowered shares of Opthea (NASDAQ:OPT – Free Report) from an outperform rating to a market perform rating in a research report released on Monday, MarketBeat reports. A number of other ...

Community, resilience and a call to action came into focus tonight as the Jewish Federation of St. Louis unveiled findings ...

Christopher Nolan’s Oppenheimer was that rare movie that was both a box office hit and a serious award winner. It also had ...

Goldman Sachs (NYSE:GS) shares continued gains for seven straight sessions, as the stock closed 2.65% higher at $580.10 on ...

Yet another face has joined the cast of Christopher Nolan’s The Odyssey, the star-studded adaptation of the Greek epic by ...

Among the titles to look out for are Mamma Mia, Kicking & Screaming, Dreamgirls, Last Night in Soho, Moneyball, Taken, Age of ...

John Leguizamo feels like Christopher Nolan is producing his upcoming take on The Odyssey like an indie film, independent of studio interference.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 7 undervalued stocks in the Capital Markets industry for Monday, March 24, 2025. Let’s take ...

In a report released today, Jay Olson from Oppenheimer maintained a Buy rating on Terns Pharmaceuticals (TERN – Research Report), with a price ...

Natixis Advisors LLC lifted its position in The Carlyle Group Inc. (NASDAQ:CG – Free Report) by 260.2% in the 4th quarter, ...

Nektar Therapeutics (NASDAQ:NKTR) operates as a biopharmaceutical company that discovers and develops therapies to treat ...

MOSCOW — USA Today sports columnist Christine Brennan will deliver the keynote address at the University of Idaho’s ...